Partner with us
Studies
/
Acute ketone supplementation in the absence of muscle glycogen utilization: Insights from McArdle disease
Human RCT
2024

Acute ketone supplementation in the absence of muscle glycogen utilization: Insights from McArdle disease

Key finding
In patients with McArdle disease, who cannot use muscle glycogen, acute ketone supplementation lowered peak power output by 11.6 percent versus placebo, while carbohydrate raised it by 21.5 percent versus ketones.
What the study did

In a randomized crossover design, 8 patients with McArdle disease and 7 healthy controls completed a submaximal test and a maximal ramp test after placebo or a 30 g ketone monoester dose; patients were also tested after 75 g of carbohydrate. Ketone supplementation induced ketosis in all participants (blood ketones 3.7 plus or minus 0.9 mM). Patients had 65 percent lower peak power output than controls (p < 0.001), and ketones impaired it further by 11.6 percent versus placebo (p = 0.001) with no effect in controls (p = 0.268). In patients, carbohydrate gave 21.5 percent higher peak power output than ketones (p = 0.001) and 12.6 percent higher than placebo (p = 0.057).

This study used [form], not goBHB. It is shown here as general ketone science. Only goBHB studies back goBHB product claims.
GOBHB//QUERY_CONSOLE271 STUDIES INDEXED
> Ask what it does, which formats it goes into, or who is already using it.
What does BHB do?goBHB in gummies?Who is using goBHB?
Let me put a person on it

A goBHB specialist picks these up and answers inside one business day.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Ask
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Pharmaceutical grade, 48 patents, and over 300 million doses in market.
Ask me about goBHB